Autori: Macdonald David
| Naslov | Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial (Article) |
| Autori | Davies Andrew Merli Francesco Mihaljevic Biljana S  Mercadal Santiago Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude Genevray Magali Zharkov Artem Dixon Mark Brewster Michael Barrett Martin MacDonald David
|
| Info | LANCET HAEMATOLOGY, (2017), vol. 4 br. 6, str. E272-E282 |
| Projekat | F Hoffmann-La Roche |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study (Meeting Abstract) |
| Autori | Davies Andrew J Mihaljevic Biljana S Mercadal Santiago Mihaylov Georgi Leppa Sirpa Cotting Denise Veenstra Klaas Zharkov Artem Dixon Mark Barrett Martin Macdonald David
|
| Info | BLOOD, (2016), vol. 128 br. 22, str. - |
| Projekat | Takeda Pharmaceutical Company Ltd; |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study (Article) |
| Autori | Davies Andrew Merli Francesco Mihaljevic Biljana S Siritanaratkul Noppadol Solal-Celigny Phillippe Barrett Martin Berge Claude Bittner Beate Boehnke Axel McIntyre Christine MacDonald David
|
| Info | LANCET ONCOLOGY, (2014), vol. 15 br. 3, str. 343-352 |
| Projekat | F Hoffmann-La Roche |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Subcutaneous Rituximab and Chemotherapy Achieves Similar Trough Levels, Safety, and Response as Intravenous Rituximab in First-Line Follicular Lymphoma: Stage 1 Results of the Phase 3 Sabrina Study (Meeting Abstract) |
| Autori | Davies Andrew Merli Francesco Mihaljevic Biljana S Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude McIntyre Christine Barrett Martin Macdonald David
|
| Info | HAEMATOLOGICA, (2013), vol. 98 br. , Suppl. 1, str. 131-132 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Pharmacokinetics (PK), Safety and Overall Response Rate (ORR) Achieved with Subcutaneous (SC) Administration of Rituximab in Combination with Chemotherapy Were Comparable to Those Achieved with Intravenous (IV) Administration in Patients (pts) with Follicular Lymphoma (FL) in the First-Line Setting: Stage 1 Results of the Phase III SABRINA Study (BO22334) (Meeting Abstract) |
| Autori | Davies Andrew J Merli Francesco Mihaljevic Biljana S Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude McIntyre Christine Barrett Martin Macdonald David
|
| Info | BLOOD, (2012), vol. 120 br. 21, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
